A comprehensive view of Hospital / Clinical Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA advisor committee supports conditional clearance of Biogen’s tofersen ALS drug; tofersen treats ALS caused by SOD1 gene mutation, which is estimated to be responsible for less than 500 of the approximately 30,000 ALS cases in the US
Published: March 23, 2023 by BioPharma Dive
Biopharma industry lobbies for tax breaks related to US-based manufacturing; PhRMA asks for 25% tax credit to offset cost of upgrading and building new manufacturing facilities in US along with reduced taxes for drugs, medical devices made in US
Published: March 22, 2023 by FiercePharma
FDA approves Regeneron’s Evkeeza evinacumab-dgnb as an adjunct to other lipid-lowering therapies for children aged 5 to 11 with homozygous familial hypercholesterolemia; HoFH is an ultra-rare inherited condition that affects about 1,300 people in the US
Published: March 22, 2023 by Regeneron Pharmaceuticals Inc.
Novo Nordisk partners with Dewpoint Therapeutics to use Dewpoint's discovery platform for two programs to identify drug candidates to treat insulin resistance and diabetic complications; deal worth up to US$745.0M
Published: March 22, 2023 by FierceBiotech
American Society of Health-System Pharmacists report supplies of some essential hospital drugs are at a 10-year low including methotrexate, cisplatin, fluorouracil, and pluvicto; drugs are often made by low-margin manufacturers with limited capacity
Published: March 21, 2023 by Axios

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count